Matthew Korenberg - 16 Sep 2024 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
President & COO
Signature
By: /s/ Andrew Reardon, Attorney-in-Fact For: Matthew E. Korenberg
Issuer symbol
LGND
Transactions as of
16 Sep 2024
Transactions value $
$226
Form type
4
Filing time
18 Sep 2024, 19:55:29 UTC
Previous filing
26 Aug 2024
Next filing
24 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Options Exercise $50,956 +914 +1.85% $55.75 50,424 16 Sep 2024 Direct
transaction LGND Common Stock Tax liability $-50,925 -485 -0.96% $105.00 49,939 16 Sep 2024 Direct
transaction LGND Common Stock Options Exercise $49,658 +849 +1.7% $58.49 50,788 16 Sep 2024 Direct
transaction LGND Common Stock Tax liability $-49,560 -472 -0.93% $105.00 50,316 16 Sep 2024 Direct
transaction LGND Common Stock Options Exercise $33,543 +671 +1.33% $49.99 50,987 16 Sep 2024 Direct
transaction LGND Common Stock Tax liability $-33,495 -319 -0.63% $105.00 50,668 16 Sep 2024 Direct
transaction LGND Common Stock Options Exercise $203,540 +3,340 +6.59% $60.94 54,008 16 Sep 2024 Direct
transaction LGND Common Stock Tax liability $-203,490 -1,938 -3.59% $105.00 52,070 16 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LGND Employee Stock Option (right to buy) Options Exercise $0 -671 -11.1% $0.000000 5,377 16 Sep 2024 Common Stock 671 $49.99 Direct F1
transaction LGND Employee Stock Option (right to buy) Options Exercise $0 -914 -3.4% $0.000000 25,949 16 Sep 2024 Common Stock 914 $55.75 Direct F2
transaction LGND Employee Stock Option (right to buy) Options Exercise $0 -849 -6.38% $0.000000 12,452 16 Sep 2024 Common Stock 849 $58.49 Direct F3
transaction LGND Employee Stock Option (right to buy) Options Exercise $0 -3,340 -15.3% $0.000000 18,500 16 Sep 2024 Common Stock 3,340 $60.94 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Option was previously reported as a Grant of 18,464 shares on February 11, 2016, which vested in full on February 11, 2020, at an exercise price of $85.79 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer.
F2 This Option was previously reported as a Grant of 30,750 shares on February 13, 2020, at an exercise price of $95.68 per share , but was adjusted pursuant to the OmniAb Inc. separation from the issuer, then vested in full on February 13, 2024.
F3 This Option was previously reported as a Grant of 15,225 shares on February 24, 2017, which vested in full on February 24, 2021, at an exercise price of $100.38 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer.
F4 This Option was previously reported as a Grant of 25,000 shares on August 06, 2015, which vested in full on August 06, 2019, at an exercise price of $104.59 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer.